Top 5 米国タンパク質市場 Companies
Archer Daniels Midland Company
Darling Ingredients Inc.
Glanbia PLC
International Flavors & Fragrances, Inc.
Kerry Group PLC
Source: Mordor Intelligence
米国タンパク質市場 Companies Matrix by Mordor Intelligence
Our comprehensive proprietary performance metrics of key 米国タンパク質市場 players beyond traditional revenue and ranking measures
This MI Matrix can diverge from simple revenue ordering because it weighs what buyers feel day to day: reliable U.S. supply, audit readiness, and recent formulation wins. It also reflects signals like new capacity ramp risk, the depth of plant and dairy protein formats, and how often customers see practical application support. Several companies score higher on execution after 2024 to 2025 launches, even when their U.S. protein ingredient footprint is still growing. Many procurement teams search for "who can supply heat stable whey or pea protein for ready to drink" and "which vendors have strong allergen documentation for soy and dairy blends." Those questions are now more urgent because U.S. labeling expectations tightened, including sesame allergen labeling effective January 1, 2023. This MI Matrix by Mordor Intelligence is better for supplier and competitor evaluation than revenue tables alone because it blends footprint, operating readiness, and recent product proof points.
MI Competitive Matrix for 米国タンパク質市場
The MI Matrix benchmarks top 米国タンパク質市場 Companies on dual axes of Impact and Execution Scale.
Analysis of 米国タンパク質市場 Companies and Quadrants in the MI Competitive Matrix
Comprehensive positioning breakdown
Bunge Limited
Morristown facility signals a sharper push into food grade plant proteins with a new soy protein concentrate line tied to the large Indiana plant. Integrated oilseed sourcing and U.S. processing depth benefit a top manufacturer, helping buyers manage cost volatility. In August 2025, Bunge also agreed to acquire IFF soy related assets, which may widen its U.S. soy ingredient reach once closed. Allergen control and labeling discipline remain essential in soy systems sold into multi ingredient foods. If Morristown ramps smoothly, Bunge could become a default scale partner for plant based reformulation. The operational risk is start up complexity across new processes and specifications.
Darling Ingredients Inc.
Combining collagen activities with PB Leiner under a 2025 plan highlights intent to accelerate collagen led growth. The company is a leading producer that is also pushing active collagen peptide profiles, with 2024 work pointing to targeted wellness positioning for brand owners. US labeling and allergen expectations keep tightening for multi ingredient foods, so consistent documentation matters even in animal derived inputs. If Darling scales clinically supported collagen concepts, it can gain higher value customer programs. A key risk is slower than expected adoption if claims scrutiny increases.
Glanbia PLC
Earnings disclosures show ongoing emphasis on nutrition solutions and protein related demand signals in 2024. Strong formulation oriented protein systems give a major supplier an edge, especially for beverages and bars that need better texture stability. US labeling compliance keeps tightening, and sesame labeling since 2023 increases customer scrutiny on shared lines and cross contact controls. If Glanbia keeps expanding functional protein systems for heat treated drinks, it can grow with ready to drink renovation cycles. The operational risk is margin pressure if dairy input volatility rises faster than contract resets.
Ingredion Incorporated
Two pea protein launches in 2024 point to focus on improving dispersibility and bar texture for U.S. and Canada customers. The company is a major supplier well positioned with application support, though protein is still one part of a broader ingredient portfolio. Sesame labeling requirements effective January 1, 2023 add compliance complexity for customers blending plant proteins with flavors and inclusions. If Ingredion ties protein with texture systems, it can reduce the need for maskers and stabilize mouthfeel. A realistic risk is slower adoption if customers consolidate vendors to fewer global contracts.
Kerry Group PLC
Financial updates through 2025 show continued volume growth and margin expansion, with the Americas called out as a key driver. Formulation led nutrition tools, including protein and hydrolysate options used in clinical and performance nutrition, benefit a leading vendor. Sesame allergen labeling since January 1, 2023 increases customer need for reliable documentation across complex ingredient stacks. If Kerry links protein systems with its fermentation and enzyme investments, it can reduce customer time to launch. A practical risk is higher scrutiny on claims and documentation as front of pack rules evolve.
Frequently Asked Questions
What should a buyer check first when selecting a whey or milk protein partner in the United States?
Start with audit readiness, traceability, and change control discipline. Then validate heat stability and sensory performance in your exact process.
How do plant proteins differ for ready to drink beverages versus bars?
Beverages often fail on solubility, viscosity, and off notes under heat. Bars often fail on hardening and moisture migration over shelf life.
Why are allergen controls now a bigger selection factor for protein ingredients?
Sesame labeling has been required since January 1, 2023, and customers are tightening allergen programs across shared lines. Suppliers with clearer documentation reduce recall and relabel risk.
When does it make sense to dual source pea or soy proteins?
Dual source when you have tight launch timelines, seasonal demand peaks, or high exposure to single crop regions. It also helps when you need both textured and isolate formats.
What signals suggest a supplier can scale with a national rollout?
Look for U.S. production assets or contracted capacity, strong on time delivery history, and the ability to hold safety stock. Consistent specs across lots matters more than nominal protein percentage.
What is the most common failure mode in protein ingredient partnerships?
Specification drift during scale up is common, especially when processing conditions change. A second frequent issue is incomplete documentation for labeling and allergen statements.
Methodology
Research approach and analytical framework
Data sourcing used public company investor releases and filings, official company newsrooms, and credible trade journalism. Private firm signals relied on certifications, facility disclosures, and observable launches. Indicators were triangulated when direct segment financials were not available. Scoring reflects U.S. protein ingredients activity only.
U.S. plants, warehouses, and customer coverage determine fill rates and qualification speed for food, feed, and nutrition accounts.
Recognition reduces approval cycles for regulated nutrition uses and supports repeat wins with large food and beverage formulators.
Relative scale in U.S. protein ingredients correlates with pricing power, contract stability, and ability to support multi site rollouts.
Dedicated protein processing, filtration, extrusion, and drying assets drive consistent specs and resilience during demand spikes.
Post 2023 launches in whey, pea, soy, collagen, and amino acid systems show who is solving taste, texture, and stability limits.
In scope performance affects service levels, capex follow through, and the ability to hold inventory for key customer programs.
